Keywords: Lundbeck, License, Cephalon, Canada, Latin America, Treanda, Nuvigil

Lundbeck to expand opportunities in Canada and Latin America with Cephalon products

Article | 10 February 2011

Print This

Danish drugmaker Lundbeck A/S (LUND: DC) says it has been granted commercial rights to several products from US firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in